Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1.
Becker CM, Farnebo FA, Iordanescu I, Behonick DJ, Shih MC, Dunning P, Christofferson R, Mulligan RC, Taylor GA, Kuo CJ, Zetter BR.
Becker CM, et al. Among authors: behonick dj.
Cancer Biol Ther. 2002 Sep-Oct;1(5):548-53. doi: 10.4161/cbt.1.5.176.
Cancer Biol Ther. 2002.
PMID: 12496487
Free article.